Treatment Adherence And Its Impact On Glycemic Control In Patients With Diabetes Mellitus Type 2 In Working Area Of Klatak Health Center Banyuwangi 2024

Andrik Hermanto; Masroni Masroni; Dedek Nabila Syakif

doi:10.62951/ijhsb.v2i1.232

Authors

Andrik Hermanto STIKES Banyuwangi
Masroni Masroni STIKES Banyuwangi
Dedek Nabila Syakif STIKES Banyuwangi

DOI:

https://doi.org/10.62951/ijhsb.v2i1.232

Keywords:

diabetes mellitus type 2, treatment adherence, glycemic control

Abstract

Background: One of the factors that can affect treatment adherence in patients with type 2 diabetes mellitus is glycemic results, if glycemic control is poor then the implementation of treatment compliance can be a motivation for glycemic control. Purpose: This study aims to determine the relationship between treatment adherence and its impact on glycemic control in patients with type 2 diabetes mellitus in the Klatak Health Center working area in 2024. Methods: This study used a cross sectional design with purposive sampling and a sample size of 35 respondents. Data collection using the MTAQDM questionnaire (modified treatment adherence questionnaire in DM patients) and observation sheets and then analyzed using the spearmen rank test. Results: All patients (100%) were in the adherence category following treatment adherence activities and almost all patients (97%) were in the diabetic category. Based on the results of the analysis obtained a P-value of 0.628 (p>0.05) which means that there is no relationship between treatment adherence and the impact of glycemic control, with a correlation of 0.085 which shows a correlation with very weak strength. Conclusion: Respondents who adhere to treatment adherence do not affect their glycemic control and adhere to treatment but HbA1c is not controlled, because many factors can affect it.

Downloads

Download data is not yet available.

References

Abdulrahman, Z., Alatrakji, M. Q., Al-Maliky, A. A., Hussein, K. I., & Hussain, S. A. (2023). Influence of metformin dose and treatment adherence on glycemic control, adiposity, and cardiovascular risk markers in Iraqi patients with T2DM. Journal of the Faculty of Medicine Baghdad, 64(4). https://doi.org/10.32007/jfacmedbagdad.6441939

Ayuningrum, C., Woelansari, E., & Suhariyadi. (2023). Kadar HbA1c, kadar TSH dan jumlah sel neutrofil pada penderita diabetes mellitus tipe 2. Penelitian Kesehatan Suara Forikes, 14(April).

Dinas Kesehatan Kabupaten Banyuwangi. (2022). Profil kesehatan Kabupaten Banyuwangi tahun 2021. Angewandte Chemie International Edition, 6(11), 951–952.

Dinkes Provinsi Jawa Timur. (2022). Profil Kesehatan Jatim Tahun 2022. Dinas Kesehatan Provinsi Jawa Timur.

Farhat, R., Assaf, J., Jabbour, H., Licha, H., Hajj, A., Hallit, S., & Khabbaz, L. R. (2019). Adherence to oral glucose lowering drugs, quality of life, treatment satisfaction, and illness perception: A cross-sectional study in patients with type 2 diabetes. Saudi Pharmaceutical Journal, 27(1). https://doi.org/10.1016/j.jsps.2018.09.005

Fayed, A., AlRadini, F., Alzuhairi, R. M., Aljuhani, A. E., Alrashid, H. R., Alwazae, M. M., & Alghamdi, N. R. (2022). Relation between diabetes-related distress and glycemic control: The mediating effect of adherence to treatment. Primary Care Diabetes, 16(2). https://doi.org/10.1016/j.pcd.2021.12.004

Hartiningsih, S. N., Nurhayati, P., Oktavianto, E., Setyorini, A., Surya, S., Yogyakarta, G., & Selatan, J. R. (2023). Pencegahan diabetes melitus dengan penyuluhan dan tes gula darah. Jurnal Peduli Masyarakat, 5(September).

Idris, A. M., Jafar, N., & Indriasari, R. (2014). Pola makan dengan kadar gula darah pasien DM tipe 2. Jurnal MKMI, 10(4).

International Diabetes Federation. (2021). IDF Diabetes Atlas 2021. Diakses dari IDF official website.

Kaaffah, S., Soewondo, P., Riyadina, W., Renaldi, F. S., & Sauriasari, R. (2021). Adherence to treatment and glycemic control in patients with type 2 diabetes mellitus: A 4-year follow-up PTM Bogor cohort study, Indonesia. Patient Preference and Adherence, 15. https://doi.org/10.2147/PPA.S318790

Ladyani, F., Agustina, R., Wasono, H. A., & Faradilla, H. (2020). Kepatuhan mengikuti prolanis BPJS dengan hasil pemeriksaan HbA1c pada penderita diabetes melitus. Jurnal Ilmiah Kesehatan Sandi Husada, 11(1). https://doi.org/10.35816/jiskh.v11i1.267

Majeed, A., Rehman, M., Hussain, I., Imran, I., Saleem, M. U., Saeed, H., Hashmi, F. K., Akbar, M., Abrar, M. A., Ramzan, B., Chaudhry, M. O., Islam, M., Nisar, N., & Rasool, M. F. (2021). The impact of treatment adherence on quality of life among type 2 diabetes mellitus patients – findings from a cross-sectional study. Patient Preference and Adherence, 15. https://doi.org/10.2147/PPA.S295012

Sa’dyah, N. A. C., Sabiti, F. B., & Susilo, S. T. (2021). Kepatuhan pengobatan terhadap indeks glikemik kontrol pada pasien diabetes melitus tipe II di Rumah Sakit Islam Sultan Agung Semarang. JPSCR: Journal of Pharmaceutical Science and Clinical Research, 6(3). https://doi.org/10.20961/jpscr.v6i3.51930

Tarigan, H. Z., & Benny, R. (2024). Hasil kadar HbA1C penderita diabetes melitus tipe 2 pada kelompok prolanis di Puskesmas Juhar tahun 2023. Corona: Jurnal Ilmu Kesehatan Umum, Psikolog, Keperawatan Dan Kebidanan, 2(1). https://doi.org/10.61132/corona.v2i1.210